drugset / Trial / NCT02882854

Guanfacine for PONV and Pain After Sinus Surgery

NCT02882854

Completed 84 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Postoperative nausea and vomiting (PONV) and pain are the most common causes of Post Anesthesia Care Unit (PACU) discharge delay, with untreated PONV occurring in 20-30% of post-surgical patients. The effect of guanfacine (GF) administration on pain and nausea scores will be assessed with two groups. One group will receive 1 mg of GF to take orally and the other group will receive a similar appearing placebo (containing no drug) to take orally.

Timeline

Start
2016-11
Primary completion
2017-02
Completion
2017-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Guanfacine Small molecule 1 mg Oral

Indications

No indication recorded.